Siemens partners with A1 on COVID variant tracking

By LabPulse.com staff writers

September 10, 2021 -- Siemens Healthineers announced that it is collaborating with A1 Life Sciences to support global efforts to track variants of SARS-CoV-2.

Siemens will offer A1 Life Sciences' Diagnovital kits that are designed to detect and identify SARS-CoV-2 mutations and variants. The Diagnovital portfolio will be offered for research use only around the world, but will not be offered initially in the U.S.

Siemens said the kits will complement the FTD SARS-CoV-2 assay, which is intended for the initial diagnosis of the infection. If a sample is identified as positive by the FTD assay, then the residual extracted nucleic acid from the original sample can be reflex tested by the appropriate Diagnovital kit or combination of kits to identify if the positive sample harbors a mutation or is a variant.

Siemens gets FDA nod for ELF test for liver fibrosis
Siemens Healthineers has been granted marketing authorization from the U.S Food and Drug Administration (FDA) for its Enhanced Liver Fibrosis (ELF) test,...
Siemens posts strong revenue, earnings growth in Q1
Benefiting from ongoing demand for products related to the COVID-19 pandemic and recovery in its core businesses, Siemens Healthineers exceeded market...
Siemens' SARS-CoV-2 test measures neutralizing antibodies
Siemens Healthineers has announced that its SARS-CoV-2 immunoglobin G antibody test is able to measure neutralizing antibodies for the virus.
Siemens donates $500K to Testing for America
Siemens Healthineers and the Siemens Foundation have partnered with Testing for America to donate $500,000 in funding and COVID-19 testing to historically...
Siemens collaborates with CDC, EC on SARS-CoV-2 assay standards
Siemens Healthineers said that it's collaborating with the U.S. Centers for Disease Control and Prevention (CDC) and the Joint Research Centre of the...

Copyright © 2021 LabPulse.com

Last Updated bc 9/13/2021 10:16:14 AM